Overall survival in the KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Spicer, J. D.; Gao, S.; Liberman, M.; Kato, T.; Tsuboi, M.; Lee, S. H.; Chen, K. N.; Dooms, C.; Majem, M.; Eigendorff, E.; Martinengo, G.; Bylicki, O.; Garassino, M. C.; Rodriguez Abreu, D.; Chaft, J.; Novello, S.; Yang, J.; Keller, S. M.; Samkari, A.; Wakelee, H. |
| Abstract Title: | Overall survival in the KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC) |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S1297 |
| End Page: | S1298 |
| Language: | English |
| ACCESSION: | WOS:001087480203538 |
| DOI: | 10.1016/j.annonc.2023.10.052 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA56 -- Source: Wos |
